Abstract:The highly toxic plant toxin ricin is one of the most known threatening toxins. Accurate and sensitive biosensing methods for the first emergency response and intoxication treatment, are always pursued in the biodefense field. Screening affinity molecules is the fundamental mainstream approach for developing biosensing methods. Compared with common affinity molecules such as antibodies and oligonucleotide aptamers, peptides have great potential as biosensing modules with more accessible chemical synthesis capability and better batch-to-batch stability than antibodies, more abundant interaction sites, and robust sensing performance towards complex environments. However, anti-ricin peptides are so scant to be screened and discovered, and an advanced screening strategy is the utmost to tackle this issue. Here, we present a new in silico-in vitro iteration-assisted affinity maturation strategy of anti-ricin peptides. We first obtained affinity peptides targeting ricin through phage display with five panning rounds of "coating-elution-amplification-enrichment" procedures. The binding affinity and kinetic parameters characterized by surface plasmon resonance (SPR) showed that we had obtained four peptides owning dissociation constants (KD) around 2~35 μM, in which peptide PD-2-R5 has the lower KD of 4.7 μM and higher stable posture to interact with ricin. We then constructed a new strategy for affinity maturity, composing two rounds of in silico-in vitro iterations. Firstly, towards the single-site alanine scanning mutation peptide library, the molecular docking predictions match the SPR evaluation results well, laying a solid foundation for designing a full saturation mutated peptide library. Secondly, plenty of in silico saturation mutation prediction results guided the discovery of peptides PD2-R5-T3 and PD-2-R5-T4 with higher affinity from only a limited number of SPR evaluation experiments. Both evolved peptides had increased affinity by about 5~20 times, i.e., KD of 230 nM and 900 nM. A primary cellular toxicity assay indicated that both peptides could protect cells against ricin damage. We further established an SPR assay based on PD-2-R5-T3 and PD-2-R5-T4 elongated with an antifouling peptide linkage and achieved good linearity with a sensitivity of 1 nM and 0.5 nM, respectively. We hope this new affinity-mature strategy will find its favorable position in relevant peptide evolution, biosensing, and medical countermeasures for biotoxins to protect society's security and human life better.

Structure-Based Affinity Maturation of A Chimeric Anti-Ricin Antibody C4c13

Novel Chimeric Anti-Ricin Antibody C4C13 with Neutralizing Activity Against Ricin Toxicity

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies

Monoclonal Antibody, Mab 4c13, an Effective Detoxicant Antibody Against Ricin Poisoning

Structural Insights into the Neutralization Mechanism of Monoclonal Antibody 6C2 Against Ricin.

A Novel Designed Single Domain Antibody on 3-D Structure of Ricin A Chain Remarkably Blocked Ricin-Induced Cytotoxicity

A Novel Neutralizing Monoclonal Antibody Against Both Ricin Toxin A and Ricin Toxin B, and Application of A Rapid Sandwich Enzyme-Linked Immunosorbent Assay

Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity

Eukaryotic expression of ScFv of anti-ricin neutralizing monoclonal antibody 4C13 and its biological activities

In Silico-Ex Vitro Iteration Strategy for Affinity Maturation of Anti-Ricin Peptides and the SPR Biosensing Application

Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody

Rational design, expression and biological activity assessment of a novel peptide based on ricin toxin antibody

A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin.

Neutralization and Binding Activity of a Human Single-Chain Antibody to Ricin Toxin

Optimization and Modification of Anti-Rhtnf-α Single Chain Variable Fragment Antibody: Effective in Vitro Affinity Maturation and Functional Expression of Chimeric Fab.

Anti-Ricin Protective Monoclonal Antibodies

Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use

Identification of Conformational Core Epitope Lys(68) in C5a Based on the 3-D Modeling Complex C5a and Its Functional Antibody F20

The Preparation of Immunoconjugate Composed of Ricin A-chain and Mab 3G11 and the Evaluation of Its Biological Activity in Vitro

Improving Antibody Affinity Through in Vitro Mutagenesis in Complementarity Determining Regions

Anti-ricin Toxin Human Neutralizing Antibodies and DMAbs Protection Against Ricin Toxin Poisoning